메뉴 건너뛰기
Journal of Cataract and Refractive Surgery
Volumn 33, Issue 8, 2007, Pages 1488-1489
Fourth-generation fluoroquinolone-resistant bacterial keratitis
Author keywords

[No Author keywords available]
Indexed keywords

ATROPINE; CEFAZOLIN; CIPROFLOXACIN; GATIFLOXACIN; MOXIFLOXACIN; TOBRAMYCIN; TOBRAMYCIN SULFATE; VANCOMYCIN;
EID: 34447633029     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2007.04.015     Document Type: Article
Times cited : (47)
References (7)
  • 1
    • 3242730154 scopus 로고    scopus 로고
    • Fourth-generation fluoroquinolones: new topical agents in the war on ocular infections
    • Mah F.S. Fourth-generation fluoroquinolones: new topical agents in the war on ocular infections. Curr Opin Ophthalmol 15 (2004) 316-320
    • (2004) Curr Opin Ophthalmol , vol.15 , pp. 316-320
    • Mah, F.S.1
  • 2
    • 27844546833 scopus 로고    scopus 로고
    • Ophthalmic infections and their anti-infective challenges
    • Alfonso E., and Crider J. Ophthalmic infections and their anti-infective challenges. Surv Ophthalmol 50 suppl 1 (2005) S1-S6
    • (2005) Surv Ophthalmol , vol.50 , Issue.SUPPL. 1
    • Alfonso, E.1    Crider, J.2
  • 3
    • 27844486699 scopus 로고    scopus 로고
    • Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®)
    • Schlech B.A., and Alfonso E. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®). Surv Ophthalmol 50 suppl 1 (2005) S7-S15
    • (2005) Surv Ophthalmol , vol.50 , Issue.SUPPL. 1
    • Schlech, B.A.1    Alfonso, E.2
  • 4
    • 2542498885 scopus 로고    scopus 로고
    • Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis
    • Dajcs J.J., Thibodeaux B.A., Marquart M.E., et al. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrob Agents Chemother 48 (2004) 1948-1952
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 1948-1952
    • Dajcs, J.J.1    Thibodeaux, B.A.2    Marquart, M.E.3
  • 5
    • 33646475165 scopus 로고    scopus 로고
    • Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery
    • Moshirfar M., Mirzaian G., Feiz V., and Kang P.C. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surgery 32 (2006) 515-518
    • (2006) J Cataract Refract Surgery , vol.32 , pp. 515-518
    • Moshirfar, M.1    Mirzaian, G.2    Feiz, V.3    Kang, P.C.4
  • 6
    • 1542708136 scopus 로고    scopus 로고
    • Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones
    • Hwang D.G. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 49 suppl 2 (2004) S79-S83
    • (2004) Surv Ophthalmol , vol.49 , Issue.SUPPL. 2
    • Hwang, D.G.1
  • 7
    • 18144431291 scopus 로고    scopus 로고
    • The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar® (gatifloxacin 0.3%) in a NZW rabbit model
    • Romanowski E.G., Mah F.S., Yates K.A., et al. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar® (gatifloxacin 0.3%) in a NZW rabbit model. Am J Ophthalmol 139 (2005) 867-877
    • (2005) Am J Ophthalmol , vol.139 , pp. 867-877
    • Romanowski, E.G.1    Mah, F.S.2    Yates, K.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.